DAVID PLATT - 31 Dec 2022 Form 5 Insider Report for BIOXYTRAN, INC (BIXT)

Signature
David Platt
Issuer symbol
BIXT
Transactions as of
31 Dec 2022
Transactions value $
-$40,119
Form type
5
Filing time
08 Feb 2023, 13:00:30 UTC
Previous filing
08 Feb 2023
Next filing
10 May 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIXT common Gift $0 0 0% $0.00* 411K 07 Jan 2020 by spouse
transaction BIXT common Award $0 0 0% $0.00* 43M 21 Sep 2018 Direct
transaction BIXT common Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities $3.8K +1.9M +86.47% $0.00* 4.1M 31 Dec 2022 by NDPD Pharma, Inc. F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIXT warrant Gift -$43.9K -122K -100% $0.36 0 13 May 2022 common 122K $2.00 by NDPD Pharma, Inc.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Management ownership in BIXT by NDPD Pharma, Inc. is consolidated under indirect ownership within Davis Platt's filing